Hongjun Jia

Title: Innovations and Contributions of Inventor Hongjun Jia

Introduction

Hongjun Jia is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. With a total of two patents to his name, his work focuses on innovative solutions for treating central nervous system injuries.

Latest Patents

Hongjun Jia's latest patents include "Pharmaceutically acceptable salts of polypeptides and methods of inhibiting the interaction between PSD-95 and N-methyl-D-aspartic acid receptor (NMDAR)." This patent provides a pharmaceutically acceptable salt of a polypeptide, which includes the amino acid sequence YEKLLDTEI or a functional variant thereof. Another significant patent is "Peptide composition for treating excitatory neurotoxicity related injuries." This application presents a pharmaceutical composition comprising a peptide with the same amino acid sequence, along with a pH adjusting agent and a filler. The peptide is recognized as an active agent for treating central nervous system injuries.

Career Highlights

Hongjun Jia is currently associated with Biocells (Beijing) Biotech Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the biotechnology sector, contributing to innovative treatments that address critical health issues.

Collaborations

Some of his notable coworkers include Huamin Han and Yujia Tian, who collaborate with him on various projects within the company.

Conclusion

Hongjun Jia's contributions to biotechnology through his patents and collaborative efforts highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.